Pure Global

Preparing Surrogates of Dementia Patients Through an Advance Care Planning Intervention - Trial NCT06152120

Access comprehensive clinical trial information for NCT06152120 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Hong Kong and is currently Enrolling by invitation. The study focuses on Dementia. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06152120
Enrolling by invitation
other
Trial Details
ClinicalTrials.gov โ€ข NCT06152120
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Preparing Surrogates of Dementia Patients Through an Advance Care Planning Intervention
Preparing Surrogates of Dementia Patients for In-the-moment Decision Making Through a Structured Advance Care Planning Intervention: A Mixed-methods Pilot Study

Study Focus

Dementia

Nurse-facilitated advance care planning intervention

Interventional

other

Sponsor & Location

The University of Hong Kong

Hong Kong, China

Timeline & Enrollment

N/A

Jun 15, 2023

Nov 30, 2024

120 participants

Primary Outcome

Modified Family Member Decision-Making Self-efficacy Scale (FDMSE) - Chinese version,Family Distress in Advanced Dementia Scale (FDAD) - Chinese version

Summary

The goal of this clinical trial is to evaluate the effects of a nurse-facilitated
 post-discharge advance care planning intervention with family surrogates of dementia patients
 on outcomes that reflect the preparedness of surrogates in decision-making.
 
 The main question it aims to answer is, whether the ACP intervention as compared with usual
 care will increase family surrogates' self-efficacy in surrogate decision-making and reduce
 their levels of distress, and increase patient comfort and reduce acute healthcare
 utilization at 2 and 6 months.
 
 Participants will be randomized to ACP intervention vs. usual care.
 
 1. patients of the Intervention group will be assessed on palliative care needs, and
 surrogates of the Intervention group will participate in 2-3 nurse-led ACP
 consultations;
 
 2. surrogates of both intervention and control groups will complete 3 surveys at different
 time points during their participation of the study.
 
 Researchers will compare the intervention group and control group to see any differences in:
 
 1. surrogate preparedness for decision-making,
 
 2. distress of surrogate and satisfaction with the care of loved one with dementia at the
 end-of-life,
 
 3. enrolment in Community Geriatric Assessment Team end-of-life care program,
 
 4. advanced care program documentation in medical record,
 
 5. patient comfort at end-of-life,
 
 6. hospitalizations in the last 6 months of life.

ICD-10 Classifications

Unspecified dementia
Alzheimer disease
Dementia in Alzheimer disease
Dementia in Alzheimer disease, unspecified
Dementia in other diseases classified elsewhere

Data Source

ClinicalTrials.gov

NCT06152120

Non-Device Trial